VRDN - Viridian Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VRDN is currently covered by 12 analysts with an average price target of $38. This is a potential upside of $19.15 (101.59%) from yesterday's end of day stock price of $18.85.

Viridian Therapeutics's activity chart (see below) currently has 45 price targets and 97 ratings on display. The stock rating distribution of VRDN is 92.19% BUY and 7.81% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 13.36% with an average time for these price targets to be met of 108.88 days.

Highest price target for VRDN is $61, Lowest price target is $22, average price target is $37.

Most recent stock forecast was given by LELAND GERSHELL from OPPENHEIMER on 07-Aug-2025. First documented stock forecast 20-Jan-2021.

Currently out of the existing stock ratings of VRDN, 59 are a BUY (92.19%), 5 are a HOLD (7.81%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$32

$15.47 (93.59%)

$28

6 days ago
(07-Aug-2025)

0/7 (0%)

$15.47 (93.59%)

Hold

$26

$9.47 (57.29%)

$27

6 days ago
(07-Aug-2025)

0/3 (0%)

$9.47 (57.29%)

Buy

$30

$13.47 (81.49%)

$27

6 days ago
(07-Aug-2025)

1/4 (25%)

$13.47 (81.49%)

112

Buy

$34

$17.47 (105.69%)

$36

7 days ago
(06-Aug-2025)

0/17 (0%)

$16.8 (97.67%)

Buy

$38

$21.47 (129.89%)

$38

3 months 6 days ago
(07-May-2025)

2/8 (25%)

$25.71 (209.19%)

369

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VRDN (Viridian Therapeutics) average time for price targets to be met?

On average it took 108.88 days on average for the stock forecasts to be realized with a an average price target met ratio 13.36

Which analyst has the current highest performing score on VRDN (Viridian Therapeutics) with a proven track record?

JASON BUTLER

Which analyst has the most public recommendations on VRDN (Viridian Therapeutics)?

Jason Butler works at JMP and has 5 price targets and 3 ratings on VRDN

Which analyst is the currently most bullish on VRDN (Viridian Therapeutics)?

Julian Harrison with highest potential upside - $44.47

Which analyst is the currently most reserved on VRDN (Viridian Therapeutics)?

Michael Higgins with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?